Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 64.43 · gapped above the open, then crossed back over prior close. High/low 66.30 at 6:30 am ET, 64.00 at 3:15 pm ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Under the terms of the BioMarin Agreement, BioMarin paid us an upfront, nonrefundable payment of $1.0 million, and reimbursed us for certain research activities.”
FILING10-K0001736730-26-000016cik 0001736730disclosed by CAMP
“• ALDURAZYME: higher sales volume due to timing of order fulfillment to Sanofi as we recognize ALDURAZYME revenues when the product is released and control is transferred to Sanofi;”
FILING10-K0001048477-26-000004cik 0001048477
“The law also requires manufacturers to offer deeply discounted FSS contract pricing for purchases of their covered drugs by the Department of Veterans Affairs, the Department of Defense, the Coast Guard, and the Public Health Service (including the Indian Health Service) in order for the manufacturer's covered drugs to be eligible for purchase by these agencies and also in order for federal funding to be available for reimbursement of the manufacturer's drugs under Medicaid and Medicare Part B.”
FILING10-K0001048477-26-000004cik 0001048477
“The law also requires manufacturers to offer deeply discounted FSS contract pricing for purchases of their covered drugs by the Department of Veterans Affairs, the Department of Defense, the Coast Guard, and the Public Health Service (including the Indian Health Service) in order for the manufacturer's covered drugs to be eligible for purchase by these agencies and also in order for federal funding to be available for reimbursement of the manufacturer's drugs under Medicaid and Medicare Part B.”
FILING10-K0001048477-26-000004cik 0001048477
“The law also requires manufacturers to offer deeply discounted FSS contract pricing for purchases of their covered drugs by the Department of Veterans Affairs, the Department of Defense, the Coast Guard, and the Public Health Service (including the Indian Health Service) in order for the manufacturer's covered drugs to be eligible for purchase by these agencies and also in order for federal funding to be available for reimbursement of the manufacturer's drugs under Medicaid and Medicare Part B.”
FILING10-K0001048477-26-000004cik 0001048477
“The law also requires manufacturers to offer deeply discounted FSS contract pricing for purchases of their covered drugs by the Department of Veterans Affairs, the Department of Defense, the Coast Guard, and the Public Health Service (including the Indian Health Service) in order for the manufacturer's covered drugs to be eligible for purchase by these agencies and also in order for federal funding to be available for reimbursement of the manufacturer's drugs under Medicaid and Medicare Part B.”
FILING10-K0001048477-26-000004cik 0001048477
“The law also requires manufacturers to offer deeply discounted FSS contract pricing for purchases of their covered drugs by the Department of Veterans Affairs, the Department of Defense, the Coast Guard, and the Public Health Service (including the Indian Health Service) in order for the manufacturer's covered drugs to be eligible for purchase by these agencies and also in order for federal funding to be available for reimbursement of the manufacturer's drugs under Medicaid and Medicare Part B.”
FILING10-K0001048477-26-000004cik 0001048477
“Our cost of sales (excluding amortization of in-licensed rights) consists of inventory costs that relate to sales of our products and the related overhead costs and royalty payments primarily to BioMarin and UWA for our PMO Products and to Nationwide for ELEVIDYS.”
FILING10-K0001193125-26-084144cik 0000873303disclosed by SRPT
“The IRA also requires the U.S. Department of Health and Human Services (HHS) to directly negotiate the selling price of a statutorily specified number of drugs and biologics each year that CMS reimburses under Medicare Part B and Part D.”
FILING10-K0001048477-26-000004cik 0001048477
“we acquired, among other things, that certain Exclusive License Agreement, by and between BioMarin Pharmaceutical Inc. ("BioMarin")”
FILING10-K0001193125-26-097558cik 0001683553disclosed by SPRB
Watchlist prices, news filtered to it, and its next report on your desk.
BioMarin Pharmaceutical Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
BioMarin Pharmaceutical Inc has 1 disclosed supplier and 9 disclosed customers. Each one is named in an SEC filing, either BioMarin Pharmaceutical Inc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
BMRN (BioMarin Pharmaceutical Inc) has 1 disclosed suppliers and 9 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: CAMP −2.53%, in healthcare.